News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
TAKANASHI KEN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
4
| TAKANASHI KEN (10% Owner) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 45,000 options to buy
@ $4.58, valued at
$206.1k
|
|
| 06/08/2023 |
4
| TAKANASHI KEN (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Bought 22,053,581 shares
@ $0.91, valued at
$20.1M
Disposed/sold 10,000 options to buy
@ $26.99, valued at
$269.9k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
Disposed/sold 30,000 options to buy
@ $3.46, valued at
$103.8k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| TAKANASHI KEN (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.46, valued at
$103.8k
|
|
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2020 |
4
| TAKANASHI KEN (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.6, valued at
$92k
|
|
| 08/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| TAKANASHI KEN (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $26.99, valued at
$269.9k
|
|
| 09/17/2019 |
4
| TAKANASHI KEN (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Converted 33,741 shares
@ $0
Converted 307,110 shares
@ $0
Bought 233,333 shares
@ $15, valued at
$3.5M
Converted 33,741 preferred shares
@ $0
Converted 307,110 preferred shares
@ $0 |
|
| 08/16/2019 |
4
| TAKANASHI KEN (10% Owner) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 10,500 options to buy
@ $20.34, valued at
$213.6k
|
|
| 08/15/2018 |
4
| TAKANASHI KEN (10% Owner) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 9,000 options to buy
@ $46.7, valued at
$420.3k
|
|
| 08/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|